Human Placental Protein Market Size

Statistics for the 2023 & 2024 Human Placental Protein market size, created by Mordor Intelligence™ Industry Reports. Human Placental Protein size report includes a market forecast to 2029 and historical overview. Get a sample of this industry size analysis as a free report PDF download.

Market Size of Human Placental Protein Industry

Human Placental Protein Market Size
share button
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR < 5.00 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Human Placental Protein Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Human Placental Protein Market Analysis

The Human Placental Protein Market is expected to register a CAGR of around 5% during the forecast period. Rising use of placental protein in cosmetics and medication to treat menopause is among the key factor triggering the growth of the human placental protein market. For instance, several products are in the human placental market which is promoting the revenue growth, Melsmon pharmaceuticals are producing pharmaceutical-grade placenta which is used for treating menopause. In addition, Japan Bio Products has Laennec which treats chronic hepatitis and another company Alber David has Inj.Placentrex. (wound healer).

The increase in R&D investments in healthcare coupled with the introduction of human placental protein in pseudo-medicines will create lucrative opportunities in the human placental protein market.

However, prolonged use of human placental proteins can cause skin dryness which hampers the market.

Human Placental Protein Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)